ICMS Announces New Guidelines
FOR IMMEDIATE RELEASE
September 13, 2011
503.877.1045
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
International Stem Cell Society Publishes New Guidelines
Portland, OR, September 13, 2011 – The International Cellular Medicine Society (“ICMS”), a professional medical association dedicated to the advancement of adult stem cell therapies, announced the publication of new draft guidelines for the practice of cell based medicine. The new draft guidelines, developed in consultation with physicians and researchers from around the world, are intended to provide a broader and more comprehensive element to the existing standards for the collection, processing and implantation of autologous, adult stem cells.
“The ICMS, with members from over 35 countries and a Treatment Registry with over 1000 patients,” says David Audley, the Executive Director of the ICMS, “Is in a unique position to promulgate these guidelines. There is no other professional medical association with more experience and more expertise in the practice of stem cell medicine.”
The draft guidelines deal with issues from patient recruitment and a code of ethics to standards for patient record keeping and minimum qualification for physicians. The new guidelines will be used as standards in the process of clinic accreditation and membership eligibility. Members of the ICMS are encouraged to review and comment on the draft guidelines.
“Our goals,” continued Audley, “Are always physician education and patient safety. These new guidelines are a significant step in delivering on these goals and advancing the field of cell based medicine.”
The complete draft guidelines can be found at the ICMS website.
# # # #
About the INTERNATIONAL CELLULAR MEDICINE SOCIETY
The ICMS, a professional medical association, is dedicated to the advancement of adult stem cell based medicine. The Society is 501(c)(3) nonprofit organization that provides best practices guidelines for the practice of cell based medicine, manages a first of its kind Treatment Registry to outcomes from cell based therapies and oversees a global accreditation program for stem cell clinics. The Society maintains two websites, www.CellMedicineSociety.org that is focused on research and education for physicians and www.StemCellWatch.com, a portal for patient awareness and education.